A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Becton Dickinson & CO stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 515,641 shares of BDX stock, worth $127 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
515,641
Previous 275,990 86.83%
Holding current value
$127 Million
Previous $64.5 Million 92.74%
% of portfolio
0.13%
Previous 0.07%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$221.47 - $242.41 $53.1 Million - $58.1 Million
239,651 Added 86.83%
515,641 $124 Million
Q2 2024

Aug 14, 2024

BUY
$225.07 - $246.17 $4.69 Million - $5.13 Million
20,843 Added 8.17%
275,990 $64.5 Million
Q1 2024

May 15, 2024

BUY
$233.45 - $247.73 $3.05 Million - $3.24 Million
13,085 Added 5.41%
255,147 $63.1 Million
Q4 2023

Feb 14, 2024

SELL
$232.24 - $267.23 $356 Million - $410 Million
-1,534,953 Reduced 86.38%
242,062 $59 Million
Q3 2023

Nov 14, 2023

BUY
$254.9 - $283.59 $372 Million - $414 Million
1,458,998 Added 458.78%
1,777,015 $459 Million
Q2 2023

May 17, 2024

BUY
$238.39 - $265.32 $15 Million - $16.7 Million
62,870 Added 24.64%
318,017 $84 Million
Q2 2023

Aug 14, 2023

BUY
$238.39 - $265.32 $8.59 Million - $9.56 Million
36,015 Added 12.77%
318,017 $84 Million
Q1 2023

May 17, 2024

BUY
$229.71 - $259.35 $5.75 Million - $6.49 Million
25,030 Added 9.74%
282,002 $69.8 Million
Q1 2023

May 15, 2023

BUY
$229.71 - $259.35 $5.75 Million - $6.49 Million
25,030 Added 9.74%
282,002 $69.8 Million
Q4 2022

May 17, 2024

BUY
$218.29 - $256.91 $398,379 - $468,860
1,825 Added 0.72%
256,972 $65.4 Million
Q4 2022

Feb 14, 2023

BUY
$218.29 - $256.91 $34.8 Million - $40.9 Million
159,268 Added 163.01%
256,972 $65.4 Million
Q3 2022

Nov 14, 2022

SELL
$51.03 - $264.23 $39,140 - $202,664
-767 Reduced 0.78%
97,704 $21.8 Million
Q2 2022

Aug 15, 2022

SELL
$234.74 - $275.42 $8.11 Million - $9.52 Million
-34,570 Reduced 25.98%
98,471 $24.3 Million
Q1 2022

May 16, 2022

SELL
$243.64 - $270.48 $28.9 Million - $32.1 Million
-118,664 Reduced 47.14%
133,041 $34.5 Million
Q4 2021

Feb 14, 2022

SELL
$230.08 - $250.94 $27.3 Million - $29.8 Million
-118,821 Reduced 32.07%
251,705 $63.7 Million
Q3 2021

Nov 15, 2021

SELL
$232.72 - $256.47 $6.26 Million - $6.9 Million
-26,904 Reduced 6.77%
370,526 $91.1 Million
Q2 2021

Aug 16, 2021

BUY
$232.65 - $254.58 $2.12 Million - $2.32 Million
9,110 Added 2.35%
397,430 $96.7 Million
Q1 2021

May 17, 2021

BUY
$232.09 - $256.88 $58.9 Million - $65.1 Million
253,620 Added 188.29%
388,320 $94.4 Million
Q4 2020

Feb 16, 2021

BUY
$221.92 - $245.94 $8.62 Million - $9.55 Million
38,831 Added 40.5%
134,700 $33.4 Million
Q3 2020

Nov 16, 2020

BUY
$215.77 - $276.76 $2.02 Million - $2.59 Million
9,344 Added 10.8%
95,869 $22.3 Million
Q2 2020

Aug 14, 2020

BUY
$219.9 - $263.41 $2.89 Million - $3.46 Million
13,125 Added 17.88%
86,525 $20.7 Million
Q1 2020

May 15, 2020

BUY
$195.69 - $279.01 $13.9 Million - $19.8 Million
71,000 Added 2958.33%
73,400 $16.9 Million
Q3 2019

Nov 14, 2019

BUY
$230.58 - $256.08 $368,928 - $409,728
1,600 Added 200.0%
2,400 $607,000
Q2 2019

Aug 14, 2019

SELL
$217.4 - $246.08 $239,140 - $270,688
-1,100 Reduced 57.89%
800 $202,000
Q4 2018

Feb 14, 2019

BUY
$204.73 - $257.93 $163,784 - $206,344
800 Added 72.73%
1,900 $426,000
Q2 2018

Apr 15, 2019

BUY
$208.1 - $233.85 $228,701 - $257,001
1,099 Added 109900.0%
1,100 $264,000
Q2 2018

Aug 14, 2018

SELL
$208.1 - $233.85 $1.38 Million - $1.55 Million
-6,646 Reduced 99.98%
1 $0
Q1 2018

May 15, 2018

BUY
$205.46 - $240.27 $1.37 Million - $1.6 Million
6,647 New
6,647 $1.44 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $70.4B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Portfolio

Follow Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.